Envista Holdings Corporation will announce its financial results for the third quarter of 2026 on November 4, 2026. The company will hold a conference call at 2:00 PM PT to discuss the results, which will be webcast and available for replay on Envista's investor website. Envista is a leading global dental company with over 30 brands, known for innovations in dental implants, orthodontics, and imaging. Investors can access the call via phone or online, with presentation materials posted in advance on the company's website.
Envista's upcoming Q3 2026 earnings call is noted here alongside Pluang's health sector market snapshot as of Oct 07, 2026 03:04 WIB: Among 100 health-sector US stocks, 47 gained and 53 declined. MESO fell 4.50% to USD 13.58 with a typical hold time of 14 days, contrasting with HUM's 4.22% rise to USD 404.74 and a longer typical hold time of 53 days. CLPT dropped 4.43% to USD 11.01, with a strong buy order activity of 79% and a shorter hold time of 9 days.
Constellation Brands reported earnings per share of $3.74, surpassing analyst estimates of $3.55, and revenue of $2.63 billion, exceeding the $2.54 billion forecast. The company saw a 5% increase in beer sales and a 17% rise in wine and spirits sales...
Tilray Brands will announce its fiscal Q1 2027 earnings on October 8, with analysts forecasting a loss of $0.16-$0.19 per share on revenues around $265-$268 million, marking about 26% growth from last year. Investors will focus on cannabis and bevera...
On October 6, 2026, five notable stocks surged between 20.9% and 52.7%, driven by various positive developments. Apimeds Pharmaceuticals rose 52.7% after its subsidiary signed a blockchain contract, while Option Care Health gained 32.7% following a $...
On October 6, five notable stocks saw significant declines, with losses ranging from 17.5% to 50.1%. ArriVent BioPharma's shares plunged 46.9% after its lung cancer treatment failed to meet the primary endpoint in a Phase 3 trial. Armada Acquisition ...
Evercore ISI raised its price target for Marvell Technology to $433 from $275, maintaining an Outperform rating. This follows Marvell's optimistic revenue projections, expecting $20 billion by fiscal 2028 and $70-$90 billion by fiscal 2031, driven by...
